Virocan Therapeutics Pvt. Ltd (Virocan) is a privately held biotech drug discovery company with expertise in cancer, obesity and cardiovascular diseases. Our strength is to connect various cutting edge discoveries in the field of RNA interference (RNAi) and synergize specific aspects of emerging trends with novel delivery systems. With this as the focus, our research has evolved collaborative models that accelerate drug discovery. We have the ability to utilize various online databases allowing rapid identification of molecular targets for various diseases that reduce the traditional drug discovery process to a fraction of its time.

Business Model
By applying a collaborative research method and by using various disease databases we rapidly identify potential new drug candidates. We also re-design existing molecules for development as novel and efficient drugs for a variety of diseases. Our comprehensive knowledge of viral gene therapy and RNA interference is a powerful resource for the generation of novel and more effective drugs. The company's major strength is the identification and validation of drug candidates followed by regulatory approval for its drug candidates.